Prelude Capital Management, LLC Outset Medical, Inc. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023
BUY
$10.52 - $20.68 $215,260 - $423,154
20,462 New
20,462 $222,000
Q4 2022

Feb 14, 2023
BUY
$12.36 - $26.41 $116,468 - $248,861
9,423 New
9,423 $243,000
Q1 2022

May 16, 2022
SELL
$34.22 - $47.24 $273,760 - $377,920
-8,000 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$36.86 - $54.98 $110,580 - $164,940
3,000 Added 60.0%
8,000 $396,000
Q2 2021

Aug 16, 2021
BUY
$41.49 - $59.92 $207,450 - $299,600
5,000 New
5,000 $250,000

Others Institutions Holding OM

# of Institutions
91
Shares Held
19.9M
Call Options Held
66.8K
Put Options Held
60.3K
View Full List

About Outset Medical, Inc.

OM Quotes by TradingView
  • Ticker OM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 48,007,300
  • Market Cap $54.2M
  • Description
  • Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...
More about OM
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email